Additionally, it can modulate the gut microbiota, suppress the TLR4/Myd88/NF-κB inflammatory pathway, and effectively combat obesity and hyperlipidemia in mice fed a high-fat diet (Sang et al., 2021). Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.